2005年5月第3期
·07/05/05 Are Estrogens Protective or Risk Factors in Brain Injury and Neurodegeneration? Reevaluation after the Women’s Health Initiative
·07/05/05 Adiponectin and Adiponectin Receptors
·07/05/05 The Search for Safer Glucocorticoid Receptor Ligands
·07/05/05 Reflections on the Discovery and Significance of Estrogen Receptor ?
·07/05/05 The Nongenomic Actions of Aldosterone
·07/05/05 Aromatase Inhibitors in the Treatment of Breast Cancer
·07/05/05 Development of Growth Hormone Secretagogues
·07/05/05 Gonadotropin-Releasing Hormone Agonists in the Treatment of Prostate Cancer
·07/05/05 Role of Aldose Reductase and Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic Options
·07/05/05 Transcriptional Regulation by Steroid Receptor Coactivator Phosphorylation
·07/05/05 Development and Potential Clinical Uses of Human Prolactin Receptor Antagonists
·07/05/05 Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis
·07/05/05 Beyond the Signal Sequence: Protein Routing in Health and Disease
·07/05/05 Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter
·07/05/05 Molecular Biology of the 3?-Hydroxysteroid Dehydrogenase/5-4 Isomerase Gene Family
·07/05/05 Nuclear Hormone Receptor Coregulator: Role in Hormone Action, Metabolism, Growth, and Development
·07/05/05 Adiponectin and Adiponectin Receptors
·07/05/05 The Search for Safer Glucocorticoid Receptor Ligands
·07/05/05 Reflections on the Discovery and Significance of Estrogen Receptor ?
·07/05/05 The Nongenomic Actions of Aldosterone
·07/05/05 Aromatase Inhibitors in the Treatment of Breast Cancer
·07/05/05 Development of Growth Hormone Secretagogues
·07/05/05 Gonadotropin-Releasing Hormone Agonists in the Treatment of Prostate Cancer
·07/05/05 Role of Aldose Reductase and Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic Options
·07/05/05 Transcriptional Regulation by Steroid Receptor Coactivator Phosphorylation
·07/05/05 Development and Potential Clinical Uses of Human Prolactin Receptor Antagonists
·07/05/05 Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis
·07/05/05 Beyond the Signal Sequence: Protein Routing in Health and Disease
·07/05/05 Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter
·07/05/05 Molecular Biology of the 3?-Hydroxysteroid Dehydrogenase/5-4 Isomerase Gene Family
·07/05/05 Nuclear Hormone Receptor Coregulator: Role in Hormone Action, Metabolism, Growth, and Development